Valentina Mancini, Farnaz Delavari, Tae-Yeon Eom, Stanislav S Zakharenko, Eric Schmitt, Stephan Eliez
{"title":"How does altered function of the hippocampus contribute to the development of psychosis?","authors":"Valentina Mancini, Farnaz Delavari, Tae-Yeon Eom, Stanislav S Zakharenko, Eric Schmitt, Stephan Eliez","doi":"10.1016/j.biopsych.2025.06.022","DOIUrl":null,"url":null,"abstract":"<p><p>This review explores the critical role of hippocampal dysfunction in the pathophysiology of psychosis, focusing on translational insights from 22q11.2 deletion syndrome (22q11DS). Converging evidence indicates that individuals with 22q11DS, one of the highest genetic risk factors for schizophrenia, exhibit a shared neurobiological vulnerability with idiopathic psychosis, characterized by cognitive decline and atypical brain development, particularly within the hippocampus. Here we explore translational evidence for hippocampal dysfunction in humans with 22q11DS and the homologous mouse models at different scales. At the neuronal level, deficits include impaired neural migration, reduced dendritic spine density of pyramidal neurons, and decreased neurogenesis. These deficits contribute to circuit-level alterations such as altered glutamatergic transmission and impaired long-term potentiation, leading to memory impairment. Moreover, hypoexcitability of parvalbumin-positive interneurons (PVI) disrupts gamma-band oscillations in the hippocampus. At the network level, reduced hippocampal-prefrontal synchrony and hypoconnectivity are observed in both mouse models and humans with 22q11DS. These findings support a model in which neurodevelopmental deficits in neural migration result in circuit dysfunction, which impacts large-scale neural dynamics and cognition. Crucially, hippocampal-prefrontal hypoconnectivity and imbalances between excitatory and inhibitory neurotransmitters are exacerbated in 22q11DS carriers with psychotic symptoms. Studies targeting dendritic spine density and PVI function in 22q11DS mouse models show potential for reversing neural and cognitive deficits, suggesting new therapeutic strategies. The effectiveness of these treatments varies with age, highlighting the need to identify critical developmental windows for intervention. In conclusion, this review emphasizes the hippocampus as a target for understanding and treating psychotic disorders.</p>","PeriodicalId":8918,"journal":{"name":"Biological Psychiatry","volume":" ","pages":""},"PeriodicalIF":9.6000,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biological Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.biopsych.2025.06.022","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
This review explores the critical role of hippocampal dysfunction in the pathophysiology of psychosis, focusing on translational insights from 22q11.2 deletion syndrome (22q11DS). Converging evidence indicates that individuals with 22q11DS, one of the highest genetic risk factors for schizophrenia, exhibit a shared neurobiological vulnerability with idiopathic psychosis, characterized by cognitive decline and atypical brain development, particularly within the hippocampus. Here we explore translational evidence for hippocampal dysfunction in humans with 22q11DS and the homologous mouse models at different scales. At the neuronal level, deficits include impaired neural migration, reduced dendritic spine density of pyramidal neurons, and decreased neurogenesis. These deficits contribute to circuit-level alterations such as altered glutamatergic transmission and impaired long-term potentiation, leading to memory impairment. Moreover, hypoexcitability of parvalbumin-positive interneurons (PVI) disrupts gamma-band oscillations in the hippocampus. At the network level, reduced hippocampal-prefrontal synchrony and hypoconnectivity are observed in both mouse models and humans with 22q11DS. These findings support a model in which neurodevelopmental deficits in neural migration result in circuit dysfunction, which impacts large-scale neural dynamics and cognition. Crucially, hippocampal-prefrontal hypoconnectivity and imbalances between excitatory and inhibitory neurotransmitters are exacerbated in 22q11DS carriers with psychotic symptoms. Studies targeting dendritic spine density and PVI function in 22q11DS mouse models show potential for reversing neural and cognitive deficits, suggesting new therapeutic strategies. The effectiveness of these treatments varies with age, highlighting the need to identify critical developmental windows for intervention. In conclusion, this review emphasizes the hippocampus as a target for understanding and treating psychotic disorders.
期刊介绍:
Biological Psychiatry is an official journal of the Society of Biological Psychiatry and was established in 1969. It is the first journal in the Biological Psychiatry family, which also includes Biological Psychiatry: Cognitive Neuroscience and Neuroimaging and Biological Psychiatry: Global Open Science. The Society's main goal is to promote excellence in scientific research and education in the fields related to the nature, causes, mechanisms, and treatments of disorders pertaining to thought, emotion, and behavior. To fulfill this mission, Biological Psychiatry publishes peer-reviewed, rapid-publication articles that present new findings from original basic, translational, and clinical mechanistic research, ultimately advancing our understanding of psychiatric disorders and their treatment. The journal also encourages the submission of reviews and commentaries on current research and topics of interest.